Jin-Xia Wang Selected Research

Jin-Xia Wang Research Topics

3	Gastroenteritis 01/2021 - 01/2017
2	Hypoxia (Hypoxemia) 01/2024 - 08/2019
2	Neoplasms (Cancer) 11/2023 - 01/2018
2	Inflammation (Inflammations) 10/2023 - 08/2022
2	Infections 08/2020 - 02/2019
1	Neuroblastoma 11/2023
1	Fibrosis (Cirrhosis) 08/2022
1	Spondylosis 08/2022
1	Necrosis 03/2022
1	Diarrhea 01/2021
1	Wounds and Injuries (Trauma) 02/2020
1	Rheumatoid Arthritis 02/2020
1	Pain (Aches) 02/2020
1	Drug-Related Side Effects and Adverse Reactions 02/2020
1	Experimental Arthritis 08/2019
1	Chemical and Drug Induced Liver Injury 08/2019
1	Atherosclerosis 08/2017

5	TabletsIBA 08/2022 - 08/2019
4	GlycosidesIBA 02/2020 - 08/2019
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2023
2	mono-(2-ethylhexyl)phthalateIBA 11/2023 - 10/2023
2	VaccinesIBA 01/2020 - 01/2017
1	AntioxidantsIBA 01/2024
1	rhodiolosideIBA 01/2024
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2024
1	Interleukin-6 (Interleukin 6)IBA 01/2024
1	AngiopoietinsIBA 11/2023
1	phthalic acid (phthalate)IBA 11/2023
1	GW 501516IBA 11/2023
1	human ANGPTL4 proteinIBA 11/2023
1	4- chloro- N- (2- ((5- trifluoromethyl- 2- pyridyl)sulfonyl)ethyl)benzamideIBA 11/2023
1	CarcinogensIBA 11/2023
1	LipidsIBA 11/2023
1	PlasticizersIBA 11/2023
1	SterolsIBA 11/2023
1	Glycerophospholipids (Phosphoglycerides)IBA 11/2023
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2023
1	Interleukin-17 (Interleukin 17)IBA 10/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2022
1	panlongqiIBA 08/2022
1	Hormones (Hormone)IBA 03/2022
1	Blood Group Antigens (Blood Groups)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Amoxicillin (Wymox)FDA LinkGeneric 08/2020
1	AcetoneIBA 02/2020
1	Freund's AdjuvantIBA 02/2020
1	Analgesics (Analgesic Drugs)IBA 02/2020
1	Rotavirus VaccinesIBA 01/2020
1	AngiotensinsIBA 08/2019
1	triptolideIBA 08/2019
1	BismuthIBA 02/2019
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2018
1	PolyproteinsIBA 08/2017
1	CytokinesIBA 08/2017
1	Interleukin-18 (Interleukin 18)IBA 08/2017
1	InflammasomesIBA 08/2017

3	Therapeutics 03/2022 - 02/2019